9JIR image
Deposition Date 2024-09-12
Release Date 2025-01-22
Last Version Date 2025-02-05
Entry Detail
PDB ID:
9JIR
Title:
Crystal structure of V30M-TTR in complex with ioxynil
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.30 Å
R-Value Free:
0.19
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Transthyretin
Gene (Uniprot):TTR
Mutations:V30M
Chain IDs:A, B
Chain Length:159
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Repurposing of Agrochemicals as ATTRv Amyloidosis Inhibitors.
J.Med.Chem. 68 1572 1586 (2025)
PMID: 39761163 DOI: 10.1021/acs.jmedchem.4c02221

Abstact

Transthyretin (TTR), a plasma protein, undergoes transformation into amyloid fibers, leading to ATTRv amyloidosis, a disease characterized by organ deposition of TTR amyloid fibrils and subsequent organ failure. Developing compounds that bind and kinetically stabilize TTR is a crucial strategy in the treatment of ATTRv amyloidosis. In this study, we narrowed 651 pesticide-related compounds down to 14 possible TTR binders through in silico screening; subsequent in vitro analysis revealed that 7 of them exhibited amyloid fibril formation inhibition activity. The herbicide components bromoxynil (6) and ioxynil (21) showed especially high ligand efficiency and efficiently inhibited amyloid fibril formation of amyloidogenic V30M-TTR. Additionally, aclonifen (9) exhibited moderate fibril formation inhibition activity, but showed selective binding to TTR comparable to that of tafamidis. While improvement is needed to the selective TTR-binding or fibril formation inhibition activity, the compounds identified herein are promising lead candidates for the development of ATTRv amyloidosis therapeutics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures